Exactech, Inc. Q3 Revenue Up 4% To $57.9 Million; Net Income Down 6% to $3.0 Million Due To Currency Losses; Q3 Diluted EPS $0.21 vs. $0.23

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today revenue of $57.9 million for the third quarter of 2014, a 4% increase over $55.7 million in the third quarter of 2013. Net income was $3.0 million, or $0.21 per diluted share, compared to $3.2 million, or $0.23 per diluted share, in the same quarter a year ago.

Help employers find you! Check out all the jobs and post your resume.